Compare Intermedia Capital Tbk. (MDIA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intermedia Capital Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Intermedia Capital Tbk. trades at Rp216 (market cap 8.08T, 258.28M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Intermedia Capital Tbk. is far larger — about 48.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Intermedia Capital Tbk. is more actively traded (258.28M versus 324K). Which is the better fit depends on your goals.
| MDIA | OBAT | |
|---|---|---|
Market Cap | 8.08T | 166.01B |
Volume | 258.28M | 324K |
Lot | 2.58M | 3.24K |
Turnover | 53.87B | 77.68M |
Average Price | 208.59 | 239.75 |
Value | 53.87B | 77.68M |
Indicative Equilibrium Price | 216 | 240 |
Indicative Equilibrium Volume | 58.51K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intermedia Capital Tbk.
PT Intermedia Capital Tbk (the Company) was established based on Notarial Deed No.5 of Firdhonal, S.H., dated February 25, 2008 under the name of PT Magazine Asia.
Read more on MDIA →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
